honoluluadvertiser.com

Sponsored by:

Comment, blog & share photos

Log in | Become a member
The Honolulu Advertiser

Updated at 12:33 p.m., Wednesday, November 22, 2006

Covance Inc moves Honolulu clinic to Waterfront Plaza

Advertiser Staff

Covance Inc., one of the world's largest drug development services companies, has relocated its Honolulu clinical research facility to One Waterfront Plaza.

The new facility features 50 beds, 12 of which are in a special monitoring ward. The Princeton, New Jersey-based Covance said the location is a state-of-the-art facility that provides pharmaceutical developers with access to a significant Asian population for Phase 1 clinical trials and other studies.

"With more than 20,000 people of Japanese, Chinese and Korean descent in its participant registry, the Honolulu clinic is an industry leader in helping pharmaceutical and biotech companies prove their drugs are safe and effective in these populations," said Covance in a news release.

Covance acquired the Honolulu site earlier this year from Radiant Research Inc. The company said the facility is one of only a few in the world that have conducted microdose studies.